NO983650L - Krystallinske progestagener - Google Patents
Krystallinske progestagenerInfo
- Publication number
- NO983650L NO983650L NO983650A NO983650A NO983650L NO 983650 L NO983650 L NO 983650L NO 983650 A NO983650 A NO 983650A NO 983650 A NO983650 A NO 983650A NO 983650 L NO983650 L NO 983650L
- Authority
- NO
- Norway
- Prior art keywords
- crystalline
- compounds
- progestagens
- compound
- progestagen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0048—Alkynyl derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Den beskrevne oppfinnelse ligger i polymorfien funnet ved den progestagene steroide forbindelse (17a)-17-hydroksy-11-metylen-19-norpregna- 4,15-dien-20-yn-3-on. Nærmere bestemt, ligger oppfinnelsen i krystallinske former av nevnte forbindelse med uventet gunstig termodynamisk stabilitet. Disse forbindelser, som hensiktsmessig kan beskrives ved henvisning til spektrale data, kan med fordel anvendes som en aktiv bestanddel i faste farmasøytiske bland- inger. De krystallinske forbindelser kan anvendes i orale kontraseptiver og ved hormonerstatningsterapi (HRT).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97202472 | 1997-08-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO983650D0 NO983650D0 (no) | 1998-08-10 |
NO983650L true NO983650L (no) | 1999-02-12 |
Family
ID=8228632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO983650A NO983650L (no) | 1997-08-11 | 1998-08-10 | Krystallinske progestagener |
Country Status (20)
Country | Link |
---|---|
US (1) | US20020010166A1 (no) |
JP (1) | JPH11116595A (no) |
KR (1) | KR19990023484A (no) |
CN (1) | CN1208043A (no) |
AR (1) | AR015146A1 (no) |
AU (1) | AU740229B2 (no) |
BR (1) | BR9803129A (no) |
CA (1) | CA2244619A1 (no) |
CO (1) | CO4960661A1 (no) |
CZ (1) | CZ252798A3 (no) |
HU (1) | HUP9801850A3 (no) |
ID (1) | ID21262A (no) |
IL (1) | IL125503A0 (no) |
NO (1) | NO983650L (no) |
NZ (1) | NZ331197A (no) |
PE (1) | PE105899A1 (no) |
PL (1) | PL327915A1 (no) |
SG (1) | SG66491A1 (no) |
TR (1) | TR199801520A1 (no) |
ZA (1) | ZA986943B (no) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2669700A (en) * | 1999-02-24 | 2000-09-14 | Akzo Nobel N.V. | Pharmaceutical compositions containing a crystalline form of the progestagen-(17alpha)-17-hydroxy-11-methylene-19-nor-pregna- 4,15-dien-20-yn-3-one (org 30659) and lactose |
-
1998
- 1998-07-24 IL IL12550398A patent/IL125503A0/xx unknown
- 1998-07-31 CA CA002244619A patent/CA2244619A1/en not_active Abandoned
- 1998-07-31 NZ NZ331197A patent/NZ331197A/en unknown
- 1998-08-03 ZA ZA986943A patent/ZA986943B/xx unknown
- 1998-08-03 SG SG1998002740A patent/SG66491A1/en unknown
- 1998-08-04 US US09/128,434 patent/US20020010166A1/en not_active Abandoned
- 1998-08-07 JP JP10223974A patent/JPH11116595A/ja active Pending
- 1998-08-07 ID IDP981110A patent/ID21262A/id unknown
- 1998-08-07 PE PE1998000708A patent/PE105899A1/es not_active Application Discontinuation
- 1998-08-10 CN CN98116281A patent/CN1208043A/zh active Pending
- 1998-08-10 AR ARP980103937A patent/AR015146A1/es unknown
- 1998-08-10 HU HU9801850A patent/HUP9801850A3/hu unknown
- 1998-08-10 AU AU78966/98A patent/AU740229B2/en not_active Ceased
- 1998-08-10 KR KR1019980032366A patent/KR19990023484A/ko not_active Application Discontinuation
- 1998-08-10 PL PL98327915A patent/PL327915A1/xx unknown
- 1998-08-10 NO NO983650A patent/NO983650L/no not_active Application Discontinuation
- 1998-08-10 BR BR9803129-5A patent/BR9803129A/pt not_active IP Right Cessation
- 1998-08-11 TR TR1998/01520A patent/TR199801520A1/xx unknown
- 1998-08-11 CO CO98045877A patent/CO4960661A1/es unknown
- 1998-08-11 CZ CZ982527A patent/CZ252798A3/cs unknown
Also Published As
Publication number | Publication date |
---|---|
CN1208043A (zh) | 1999-02-17 |
ZA986943B (en) | 1999-02-04 |
HUP9801850A2 (hu) | 1999-04-28 |
CO4960661A1 (es) | 2000-09-25 |
NO983650D0 (no) | 1998-08-10 |
CA2244619A1 (en) | 1999-02-11 |
US20020010166A1 (en) | 2002-01-24 |
PE105899A1 (es) | 1999-10-30 |
NZ331197A (en) | 1998-11-25 |
CZ252798A3 (cs) | 1999-06-16 |
ID21262A (id) | 1999-05-12 |
HUP9801850A3 (en) | 2000-01-28 |
TR199801520A1 (xx) | 1999-02-22 |
PL327915A1 (en) | 1999-02-15 |
BR9803129A (pt) | 2000-05-02 |
AU740229B2 (en) | 2001-11-01 |
IL125503A0 (en) | 1999-03-12 |
AR015146A1 (es) | 2001-04-18 |
AU7896698A (en) | 1999-02-18 |
JPH11116595A (ja) | 1999-04-27 |
SG66491A1 (en) | 1999-07-20 |
KR19990023484A (ko) | 1999-03-25 |
HU9801850D0 (en) | 1998-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20042596L (no) | Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1 | |
MXPA02011632A (es) | Inhibidores de 11-beta-hidroxiesteroide deshidrogenasa tipo 1. | |
NO20052130L (no) | Sterk inhibitor for HCV-serin-protease | |
MXPA04006553A (es) | Compuesto de 4-oxoquinolina y uso del mismo como inhibidor de integrasa de vih. | |
HUP0104718A2 (hu) | Mikronizált eplerenon kompozíciók és eljárás az előállításukra | |
MXPA04004837A (es) | Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1. | |
MXPA04004842A (es) | Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1. | |
DK1446128T3 (da) | Anvendelse af östrogenforbindelser i kombination med progestogenforbindelser i hormonsubstitutionsbehandling | |
DK1206467T3 (da) | N-heterocykliske derivater som NOS-inhibitorer | |
AU1266900A (en) | Betulinic acid and derivatives thereof useful for the treatment of neuroectodermal tumors | |
KR970010784A (ko) | 11-(치환된 페닐)-에스트라-4,9-디엔 유도체 | |
BR9709062A (pt) | Composto, composição farmacêutica, e, uso de um composto. | |
KR950031060A (ko) | 골다공증 치료용 약제학적 조성물 | |
RS50768B (sr) | Režim doziranja i farmaceutska formulacija za urgentnu zaštitu | |
WO2005047303A3 (en) | NOVEL 17β HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS | |
AP2003002716A0 (en) | Medicinal compositions containing propenone derivatives. | |
AU2658695A (en) | N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors | |
DE69836678D1 (de) | Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf) | |
PL374317A1 (en) | Composition containing an androgenous 11beta-halogen steroid and a progestational hormone, and male contraceptive based on said composition | |
RS44204A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
BR0009476A (pt) | Esteróides imunomoduladores, em particular hemidrato de 16 alfa-bromoepiandrosterona | |
UA85203C2 (en) | 17β HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS | |
NO983650L (no) | Krystallinske progestagener | |
BR0312123A (pt) | Agentes de gnrh não peptìdicos, composições farmacêuticas e métodos para o seu uso | |
DE69525181D1 (de) | Tnf-rezeptor und steroidhormon dhea in einer kombinationstherapie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |